coronavirida
famili
nidoviral
order
largest
known
rna
genom
increas
likelihood
genet
variat
wild
domest
anim
cov
caus
mild
sever
enter
respiratori
neurolog
system
diseas
human
caus
common
cold
addit
sar
sarscov
necrot
enterocol
newborn
associ
covlik
agent
anim
human
infect
group
cov
bird
infect
group
rodent
bat
also
infect
cov
group
cov
includ
human
cov
mous
hepat
viru
rat
cov
bovin
cov
porcin
hemaglutin
encephalomyel
viru
equin
cov
canin
respiratori
cov
interspeci
transmiss
cov
well
document
anim
bird
may
act
natur
reservoir
covrel
diseas
domest
anim
human
studi
conduct
us
center
diseas
control
prevent
cdc
found
evid
sarscov
transmiss
bat
human
among
bat
biologist
alway
time
test
subject
expos
bat
blood
saliva
tissu
bite
scratch
virolog
pathogenesi
sarscov
discuss
weiss
navasmartin
sarscov
isol
himalayan
mask
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonid
chines
ferretbadg
melogal
moschata
wild
live
market
shenzhen
china
mammalian
speci
suscept
sarscov
includ
cynomolgu
macaqu
macaca
faciculari
rhesu
macaqu
macaca
mulatta
african
green
monkey
cercopithecu
aethiop
ferret
mustela
furo
golden
hamster
mesocricetu
auratu
guinea
pig
cavia
porcellu
mous
mu
musculu
rat
rattu
rattu
domest
cat
feli
domesticu
pig
su
scrofa
common
marmoset
suscept
sarscov
develop
diseas
similar
human
ill
pneumonia
hepat
mild
coliti
wateri
diarrhea
slcov
isol
chines
horsesho
bat
speci
rhinolophu
pearsoni
r
macroti
r
pussilu
r
ferrumequinum
cavedwel
fruit
bat
rousettu
leschenault
serolog
polymeras
chain
reaction
pcr
evid
infect
close
relat
sarscov
virus
bat
found
chines
provinc
km
apart
hong
kong
strongli
suggest
bat
natur
reservoir
cov
isol
bat
speci
peopl
republ
china
r
sinicu
r
pearsoni
r
ferrumequinum
r
macroti
r
ferrumequinum
myoti
ricketti
miniopteru
magnat
pusillu
schreibersii
scolophlu
kuhlii
tylonycteri
pachypu
pipistreliu
abramu
p
pipistrellu
unit
state
wild
zookept
anim
cov
isol
bat
myoti
occultu
eptesicu
fuscu
sambar
deer
cevu
unicolor
whitetail
deer
odocoileu
virginianu
waterbuck
kobu
ellipsipyrmnu
elk
cervu
elephu
carib
rangif
tarandu
sitatunga
tragelaphu
spekei
giraff
giraffa
camelopardali
musk
oxen
ovibu
moschatu
bat
sold
live
market
southern
china
consumpt
use
tradit
medicin
one
observ
civet
becom
ill
natur
occur
infect
howev
inject
sarscov
develop
fever
lethargi
loss
aggress
decreas
appetit
result
evid
infect
wild
farm
civet
make
unlik
anim
reservoir
slcov
greater
genet
variat
sarscov
pteropid
bat
fli
fox
fruit
bat
reservoir
hendra
nipah
virus
emerg
infect
australia
southeast
asia
henipavirus
batderiv
virus
greater
genet
divers
virus
isol
nipah
viru
outbreak
malaysia
bangladesh
bat
toler
viral
infect
without
outward
sign
suggest
civet
becam
infect
market
captiv
proxim
bat
civet
naiv
speci
turn
infect
man
hamster
guinea
pig
young
mice
week
old
rat
cat
pig
remain
asymptomat
experiment
infect
sarscov
rat
particular
problem
ubiquit
anim
contact
first
human
case
guangdong
rat
bird
suscept
sarscov
infect
structur
membran
protein
sarscov
spike
protein
similar
bat
slcov
similar
civet
cov
membran
envelop
e
protein
similar
respect
variat
protein
believ
respons
host
rang
interspeci
transmiss
adapt
pathogen
novel
cov
isol
verocel
cultur
detect
revers
transcriptas
pcr
rtpcr
patient
respiratori
secret
diseas
reproduc
inocul
cynomolgu
macaqu
identifi
anim
negativecontrast
electron
microscopi
rtpcr
genom
complet
sequenc
analysi
indic
sarscov
close
relat
cov
group
post
mortem
highest
concentr
viru
found
lung
small
bowel
probabl
relat
densiti
sarscov
receptor
alveolar
epithelium
highest
intens
infect
follow
alveolar
macrophag
littl
involv
bronchiolar
epithelium
involv
bronchial
epithelium
region
lymph
node
autopsi
studi
reveal
littl
patholog
upper
respiratori
tract
peribronchi
hilar
adenopathi
limit
serou
pleural
effus
pronounc
pulmonari
edema
consolid
histolog
diffus
alveolar
damag
pulmonari
edema
hyalin
membran
area
reveal
interstiti
thicken
patient
display
intraalveolar
organ
exud
granul
tissu
small
airway
especi
subpleur
area
atyp
pneumocyt
either
multinucl
giant
cell
cell
larg
atyp
nuclei
present
patient
vascular
fibrin
thrombi
common
often
accompani
pulmonari
infarct
patient
evid
bacteri
includ
methicillinresist
staphylococcu
aureu
stenotrophomona
maltophilia
fungal
aspergillu
candida
speci
viral
cytomegaloviru
superinfect
virallik
particl
repres
viral
nucleocapsid
seen
scanti
pneumocyt
spleen
lymph
node
histolog
reveal
lymphocyt
deplet
white
pulp
atrophi
spleen
patholog
chang
biopsi
autopsi
specimen
gastrointestin
tract
minim
mucos
lymphoid
deplet
evid
viral
replic
found
small
larg
intestin
patient
die
acut
renal
failur
arf
patholog
reveal
acut
tubular
necrosi
without
glomerular
diseas
central
nervou
system
edema
degener
neuron
evid
viral
infect
bone
marrow
abnorm
patient
includ
hemophagocytosi
necrosi
infiltr
adren
gland
monocyt
lymphocyt
destruct
follicular
epitheli
cell
thyroid
germ
cell
destruct
apoptot
spermatogenet
cell
test
edema
atrophi
myocardi
fiber
seen
myofib
degener
myofib
necrosi
macrophag
infiltr
myofib
atrophi
rare
regen
fiber
present
necrot
fiber
accumul
igg
igm
fibrinogen
without
chronic
inflammatori
lymphocyt
infiltr
anim
model
cat
ferret
also
known
lsign
sarscov
bind
receptor
mediat
proteasomedepend
viral
degrad
express
cytokeratin
respiratori
epithelia
sarscov
receptor
respiratori
tract
although
effici
sarscov
antigen
express
lesion
develop
respiratori
tract
anim
day
post
inocul
diffus
alveolar
damag
associ
sarscov
antigen
express
evolv
infect
anim
cat
develop
uniqu
tracheobronchoaden
antigen
express
seen
type
ii
pneumocyt
serou
cell
tracheobronchi
submucos
gland
cat
serou
epitheli
cell
type
ii
pneumocyt
ferret
differ
anim
model
human
human
develop
syncyti
hyalin
membran
reninangiotensin
system
play
import
role
pathogenesi
pulmonari
hypertens
pulmonari
fibrosi
ace
cleav
angiotensin
produc
peptid
angiotensin
ii
reduc
angiotensin
ii
level
knockout
mous
studi
demonstr
protect
anim
ard
sarscov
inject
inject
sarscov
protein
reduc
express
worsen
ard
highli
express
enterocyt
small
intestin
organ
becom
infect
sarscov
organ
cell
type
without
express
may
becom
infect
endotheli
cell
express
high
level
becom
infect
anoth
postul
patholog
mechan
human
long
interspers
nuclear
element
endonucleas
domain
protein
seem
target
sarsassoci
autoantibodi
antibodi
found
patient
sar
present
viru
may
detect
patient
rtpcr
nasopharyng
aspir
stool
urin
site
posit
patient
patient
remain
posit
least
site
discharg
shed
peak
day
onset
symptom
patient
stop
shed
anoth
day
rang
day
median
time
becom
rtpcr
neg
day
rang
day
viru
surviv
dri
inanim
surfac
long
day
inactiv
ppm
hypochlorit
laundri
bleach
exposur
minut
less
ethanol
household
deterg
disinfect
wast
system
elimin
rodent
cockroach
care
garbag
dispos
consid
import
prevent
infect
standard
disinfect
deterg
disinfect
approv
environment
protect
agenc
recommend
decontamin
see
center
diseas
control
prevent
public
health
guidanc
communitylevel
prepared
respons
sever
acut
respiratori
syndrom
sar
version
avail
http
wwwcdcgovncidodsarsguidanceipdf
healthcarepdf
diseas
contain
problemat
viru
found
fecal
sampl
amoy
garden
outbreak
yet
rectal
swab
posit
hospitalacquir
sar
case
taiwan
hospit
attribut
nosocomi
respiratori
spread
prevent
spread
sarscov
made
difficult
potenti
spread
fomit
convers
droplet
airborn
transmiss
incub
period
averag
day
usual
day
hong
kong
toronto
day
may
long
day
day
diseas
onset
hospit
absenc
specif
symptom
often
present
atyp
communityacquir
pneumonia
lack
reliabl
diagnost
test
earli
diseas
put
hcw
particular
risk
atyp
present
includ
diarrhea
bloodi
diarrhea
without
respiratori
symptom
earli
diagnosi
depend
sole
exposur
sar
travel
epidem
endem
area
make
sarscov
ideal
agent
terrorist
molecular
studi
separ
human
sarscov
isol
earli
middl
late
phase
outbreak
virus
human
sarscov
isol
sporad
case
area
china
close
relat
anim
isol
human
isol
pandem
outbreak
find
suggest
independ
speciescross
event
exclud
superspread
event
ss
sarscov
calcul
basecas
reproduct
number
r
attack
rate
rang
risk
exposurehour
ss
includ
patient
excret
high
titer
viru
aerosol
gener
contamin
environ
fomit
close
contact
health
care
set
instanc
result
mani
infect
singl
patient
ss
occur
hotel
hong
kong
health
care
facil
hong
kong
beij
singapor
toronto
air
flight
hong
kong
beij
amoy
garden
highris
apart
hong
kong
resid
develop
sarscov
infect
high
concentr
sarscov
found
indoor
aerosol
origin
plumb
build
viru
surviv
day
sewag
c
day
c
aerosol
enter
apart
bathroom
drain
infect
inhabit
subsequ
blown
prevail
wind
contamin
build
meteorolog
factor
ambient
wind
low
mix
height
prevent
dispers
aerosol
decreas
temperatur
enabl
viru
surviv
longer
period
believ
play
crucial
role
outbreak
posit
associ
although
caus
effect
air
pollut
sar
casefat
rate
exist
nasopharyng
swab
sarscov
concentr
directli
relat
distanc
index
case
individu
patient
adjac
unit
block
amoy
garden
block
e
index
case
higher
viral
concentr
live
away
patient
live
within
block
suggest
airborn
spread
possibl
rodent
fomit
play
role
could
exclud
factor
contribut
nosocomi
contagion
includ
less
bed
lack
handwash
facil
lack
chang
facil
staff
resuscit
perform
ward
hcw
work
symptomat
patient
requir
oxygen
therapi
patient
requir
posit
airway
pressur
ventil
viral
load
might
high
shed
prolong
immunocompromis
patient
addit
airflow
around
oxygen
mask
dissemin
potenti
infecti
particl
use
close
oxygen
deliveri
mask
respiratori
filter
prevent
droplet
dispers
without
increas
posit
pressur
endtid
co
recommend
contain
spread
diseas
includ
hand
wash
appropri
wellfit
facemask
isol
airborn
precaut
quarantin
asymptomat
contact
thu
significantli
decreas
time
onset
diseas
isol
applic
infect
control
procedur
singapor
result
signific
drop
r
week
r
week
r
week
r
hcw
remain
signific
risk
initi
infect
control
precaut
toronto
risk
factor
includ
perform
highrisk
patient
care
procedur
inconsist
use
person
protect
equip
fatigu
lack
adequ
train
group
hcw
wore
jewelri
ate
meal
unit
work
receiv
formal
train
hcw
interview
indic
visit
least
room
patient
sar
wear
mask
mask
fittest
late
outbreak
forti
percent
reus
item
stethoscop
goggl
clean
equip
elsewher
ward
onethird
hcw
assist
endotrach
intub
patient
sar
evid
sarscov
transmit
hcw
cardiopulmonari
resuscit
simul
base
stochast
susceptibleinfectedrecov
dynam
hospit
social
network
predict
hcw
particularli
physician
principl
vector
diseas
model
suggest
control
outbreak
could
achiev
effect
restrict
physician
visit
differ
hospit
unit
ward
vaccin
physician
individu
widespread
contact
prioriti
vaccin
becom
avail
anoth
studi
screen
asymptomat
hcw
nasopharyng
swab
sensit
secondnest
rtpcr
test
detect
less
copi
rnamm
individu
consid
first
linewel
protect
hcw
care
patient
infect
sarscov
employ
glove
gown
goggl
mask
secondnest
rtpcr
assay
sarscov
posit
hcw
asymptomat
hcw
becam
seroposit
despit
rtpcr
posit
hcw
posit
secondnest
rtpcr
either
requir
stay
home
central
accommod
day
followup
test
second
third
test
alway
neg
investig
addit
recommend
addit
regular
nasopharyng
swab
screen
daili
record
temperatur
firstlin
hcw
toronto
case
investig
contact
requir
health
depart
attent
contact
compli
quarantin
recommend
contact
quarantin
period
could
contact
sarscov
transmiss
limit
nosocomi
household
spread
health
depart
expect
quarantin
contact
investig
possibl
case
case
sar
meet
epidemiolog
criteria
case
definit
probabl
sar
includ
fever
greater
c
histori
fever
preced
hour
new
infiltr
chest
radiograph
consist
pneumonia
chill
cough
malais
myalgia
histori
exposur
posit
test
sarscov
statist
analysi
use
frequentist
bayesian
approach
appli
sar
show
border
ie
airport
entri
screen
diagnost
test
rare
efficaci
method
prevent
import
diseas
countri
resourc
place
entri
point
health
care
system
intern
border
patient
present
flulik
symptom
fever
chill
cough
malais
patient
develop
dyspnea
recurr
persist
fever
thirti
percent
significantli
improv
within
week
mortal
patient
less
year
old
older
patient
male
sex
comorbid
condit
eg
diabet
hyperglycemia
independ
diabet
chronic
hepat
increas
mortal
overal
patient
without
comorbid
condit
mortal
respect
advanc
age
high
admiss
neutrophil
count
initi
elev
lactic
dehydrogenas
ldh
independ
correl
advers
outcom
first
week
march
hong
kong
sar
epidem
outbreak
human
metapneumoviru
hmpv
hmpv
rna
detect
nasopharyng
aspir
sar
patient
hcw
epidemiolog
associ
sar
unit
risk
factor
hmpv
infect
coinfect
patient
cough
coryza
statist
signific
sever
ill
outcom
differ
among
sole
infect
sarscov
infect
virus
tabl
describ
laboratori
find
wateri
diarrhea
part
initi
present
approxim
patient
outbreak
amoy
garden
hong
kong
patient
develop
diarrhea
posit
rtpcr
sarscov
stool
sampl
cumul
patient
develop
selflimit
wateri
diarrhea
mean
ae
day
durat
time
ill
hcw
believ
acquir
sar
respiratori
rout
develop
diarrhea
studi
none
hcw
posit
rectal
swab
sarscov
rtpcr
contact
sar
patient
asymptomat
infect
frequent
symptom
fever
higher
c
hour
symptom
vari
nonspecif
includ
sore
throat
myalgia
nausea
patient
initi
chest
radiograph
may
normal
pregnanc
infant
born
pregnant
women
sar
seem
acquir
infect
vertic
transmiss
studi
death
among
pregnant
women
mortal
anoth
studi
patient
requir
intub
compar
nonpregn
patient
four
patient
first
trimest
spontan
miscarriag
patient
becam
ill
week
gestat
deliv
prematur
two
pregnant
women
recov
carri
babi
term
pregnanc
complic
intrauterin
growth
restrict
newborn
present
clinic
sar
evid
sarscov
infect
examin
cord
blood
placenta
followup
neonat
serolog
sever
acut
respiratori
syndrom
februari
june
outbreak
sar
occur
toronto
canada
children
potenti
exposur
sar
classifi
suspect
sar
develop
symptom
within
day
exposur
probabl
sar
chest
radiograph
reveal
lower
respiratori
tract
diseas
clinic
diseas
manifest
includ
follow
fever
higher
c
probabl
suspect
respiratori
symptom
probabl
suspect
headach
lethargi
vomit
diarrhea
minor
patient
children
exhibit
irrit
myalgia
focal
minor
alveolar
infiltr
seen
probabl
case
singl
case
progress
lower
lobe
infiltr
perihilar
peribronchi
thicken
patient
bilater
infiltr
girl
develop
respiratori
distress
requir
supplement
oxygen
nine
children
receiv
intraven
ribavirin
child
receiv
intraven
aerosol
ribavirin
clinic
cours
children
describ
mild
brief
publish
report
transmiss
sarscov
pediatr
patient
sar
children
exercis
impair
radiolog
abnorm
persist
month
diagnosi
thinsect
comput
tomographi
ct
abnorm
persist
children
month
diagnosi
often
minor
common
laboratori
find
lymphopenia
children
exhibit
neutropenia
mild
thrombocytopenia
elev
liver
enzym
aspart
transaminas
alanin
transaminas
alt
ldh
elev
creatin
phosphokinas
cpk
case
two
month
onset
ill
children
report
selflimit
thin
shed
hair
telogen
effluvium
patient
dialysi
higher
risk
acquir
sar
display
typic
symptom
fever
myalgia
chill
rigor
gastrointestin
symptom
less
sever
although
patient
sought
medic
attent
later
stage
diseas
chang
chest
radiograph
tend
less
sever
patient
dialysi
vs
bilater
multifoc
chang
patient
dialysi
shed
viru
longer
period
greater
transfus
requir
requir
longer
hospit
similar
mortal
compar
control
group
studi
patient
suspect
sarscov
infect
manag
outpati
serolog
evid
infect
five
patient
normal
chest
radiograph
patient
symptom
symptom
complain
myalgia
fever
cough
chill
howev
half
patient
followup
serolog
serolog
test
asymptomat
close
contact
individu
found
igg
sarscov
antibodi
none
household
contact
sar
patient
show
serolog
evid
infect
anoth
studi
symptomat
household
contact
identifi
individu
travel
sar
endem
area
investig
conclud
individu
mild
subclin
diseas
complic
hlab
haplotyp
taiwanes
patient
hlab
hong
kong
chines
patient
allel
low
defici
mannos
bind
lectin
serum
level
increas
express
gene
increas
concentr
seem
risk
factor
sar
liverlymph
node
specif
intercellular
adhes
molecul
grab
nonintegrin
homozygot
individu
lsign
lower
risk
hong
kong
chines
patient
interferon
gamma
ifng
aa
ifng
genotyp
associ
increas
risk
develop
sar
excess
induct
proinflammatori
cytokin
chemokin
recruit
immun
cell
postul
mechan
seriou
lung
injuri
patient
discharg
sarscov
infect
frequent
abnorm
chest
radiograph
patient
abnorm
includ
patchi
opacif
volum
loss
abnorm
persist
patient
day
discharg
opacif
volum
loss
remain
unchang
patient
ct
studi
patient
reveal
develop
pulmonari
fibrosi
develop
ct
evid
pulmonari
fibrosi
older
mean
age
vs
year
men
malefemal
ratio
often
admit
intens
care
unit
icu
vs
higher
peak
ldh
level
ul
vs
ul
often
requir
puls
steroid
therapi
radiograph
opacif
abnorm
segment
thinsect
ct
ct
find
ae
day
reveal
air
trap
ground
glass
opac
reticul
parenchym
band
bronchiectasi
consolid
honeycomb
second
ct
ae
day
demonstr
resolut
ground
glass
interstiti
opac
air
trap
persist
incid
spontan
pneumothorax
nonventil
patient
half
patient
pneumothorax
bilater
studi
patient
higher
ldh
level
receiv
steroid
patient
receiv
mechan
ventil
develop
pneumomediastinum
subcutan
emphysema
develop
pneumothorax
cardiovascular
complic
seen
patient
overal
patient
becam
hypotens
week
week
week
tachycardia
could
explain
either
fever
hypotens
present
patient
week
week
week
tachycardia
weakli
associ
steroid
therapi
second
third
week
ill
persist
followup
patient
transient
bradycardia
seen
patient
revers
cardiomegali
without
heart
failur
occur
patient
transient
atrial
fibril
seen
patient
arf
arf
occur
patient
admit
probabl
sar
patient
men
older
often
underli
ill
diabet
vs
p
heart
failur
vs
p
increas
incid
respiratori
failur
vs
p
death
vs
p
patient
initi
normal
serum
creatinin
incid
arf
occur
day
ill
median
day
studi
patient
die
vs
patient
without
arf
p
complic
arf
hypotens
sepsi
gastrointestin
bleed
ard
rhabdomyolysi
studi
patient
rhabdomyolysi
die
multipl
organ
failur
osteonecrosi
joint
pain
common
complaint
sarscov
infect
osteonecrosi
hip
knee
risk
patient
receiv
steroid
therapi
risk
complic
low
total
dose
steroid
therapi
higher
total
dose
steroid
therapi
therapi
day
risk
tumor
necrosi
factor
polymorph
promot
region
ac
genotyp
associ
suscept
sarscov
infect
risk
interstiti
lung
fibrosi
repres
risk
factor
femor
head
necrosi
bone
densiti
reduc
patient
receiv
steroid
therapi
bone
resorpt
format
biochem
test
predict
develop
complic
bacteri
fungal
superinfect
relat
prolong
durat
ill
prolong
ventil
support
highdos
steroid
therapi
report
infect
includ
aspergillu
speci
mucor
speci
pseudomona
aeruginosa
klebsiella
speci
methicillinresist
staphylococcu
aureu
ahemolyt
streptococcu
speci
cytomegaloviru
endocrin
hypocortisol
found
survivor
sarscov
infect
patient
hypocortisol
transient
subclin
thyrotoxicosi
almost
biochem
either
central
primarili
hypothyroid
hypothalamicpituitaryadren
axi
abnorm
return
normal
within
year
hepat
reactiv
hepat
common
find
patient
elev
alt
admiss
develop
alt
elev
cours
ill
concomit
hepat
b
associ
advers
clinic
outcom
sever
hepat
liver
damag
seem
directli
caus
sarscov
rather
hypoxia
psychiatr
complic
significantli
neg
affect
qualiti
life
seen
survivor
ard
intens
care
treatment
patient
suffer
least
clinic
signific
psychiatr
symptom
point
preval
posttraumat
stress
disord
ptsd
diagnos
patient
nonspecif
anxieti
patient
preval
ptsd
hospit
discharg
year
later
sever
acut
respiratori
syndrom
respect
ptsd
depress
associ
longer
length
stay
icu
longer
durat
mechan
ventil
sedat
ptsd
diagnos
toronto
resid
quarantin
respond
voluntari
survey
presenc
ptsd
correl
depress
symptom
durat
quarantin
hcw
like
suffer
ptsd
percept
risk
signific
impact
work
routin
depress
affect
assign
highrisk
unit
hcw
care
patient
sar
experienc
less
ptsd
approxim
onefifth
patient
present
normal
chest
radiograph
develop
infiltr
within
day
median
day
onset
fever
present
opac
chest
radiograph
unilater
remaind
bilater
mean
parenchym
involv
rang
opacif
radiograph
chang
appear
peak
day
correspond
approxim
initi
treatment
steroid
involv
lung
zone
bilater
versu
unilater
diseas
associ
higher
risk
icu
admiss
death
patient
die
older
ae
year
vs
ae
year
p
higher
frequenc
comorbid
condit
abnorm
thinsect
ct
adult
improv
time
extent
persist
find
correl
advanc
age
sever
diseas
diffus
capac
adjust
hemoglobin
children
sar
distinguish
form
viral
pneumonia
one
report
indic
children
present
normal
chest
radiograph
common
chest
radiograph
find
consolid
sometim
peripher
multifoc
diseas
peribronchi
thicken
rare
pleural
effus
interstiti
diseas
observ
anoth
report
case
abnorm
chest
radiograph
laboratori
test
sensit
rtpcr
collect
first
day
ill
inadequ
clinic
score
emerg
room
triag
sar
outbreak
febril
patient
otherwis
healthi
seem
sensit
specif
figur
gener
noninfluenza
season
promis
rtpcr
develop
detect
virem
blood
donor
sampl
earli
symptomat
diseas
confirm
infect
made
identifi
sarscov
nucleocapsid
n
protein
serum
n
antigencaptur
enzymelink
immunosorb
assay
elisa
n
antigencaptur
chemiluminesc
immunoassay
serolog
accomplish
commerci
avail
indirect
elisa
kit
indirect
immunofluoresc
assay
ifa
elisa
ifa
result
nearli
alway
tend
agreement
serolog
posit
patient
first
week
pair
serolog
posit
patient
rtpcr
posit
patient
sarscov
patient
serum
fals
crossreact
elisa
western
blot
human
tlymphotrop
viru
htlvii
viral
cultur
perform
african
green
monkey
vero
cell
monolay
confirm
rtpcr
rna
amplif
realtim
nucleic
acid
sequencebas
amplif
seem
least
sensit
rtpcr
first
week
ill
rtpcr
diagnost
yield
tracheal
aspir
stool
pool
throat
nasal
swab
rectal
swab
nasal
swab
throat
swab
nasopharyng
aspir
yield
first
week
ill
throat
wash
urin
lower
yield
respect
viral
cultur
lower
yield
specimen
posit
cultur
neg
rtpcr
first
day
ill
seem
nasopharyng
aspir
throat
swab
use
detect
viru
wherea
stool
specimen
valuabl
day
ill
sensit
urin
sampl
littl
use
clinic
specimen
remain
stabl
c
c
week
may
store
later
test
rtpcr
detect
sarscov
day
respiratori
secret
stool
urin
patient
viru
isol
cultur
week
quantit
rtpcr
rtqpcr
use
measur
viral
load
nasopharyng
aspir
obtain
day
onset
symptom
correl
oxygen
desatur
need
mechan
ventil
diarrhea
abnorm
liver
function
studi
death
serum
rtqpcr
predict
oxygen
desatur
need
mechan
ventil
death
stool
viral
load
associ
diarrhea
urin
viral
load
correl
abnorm
urin
analysi
nasopharyng
viral
load
tend
peak
day
decreas
less
initi
level
day
seem
howev
worsen
clinic
condit
week
directli
relat
viral
replic
immunopatholog
infect
applic
surfaceenhanc
laser
desorptionion
seldi
proteinchip
technolog
produc
proteom
fingerprint
examin
common
proteom
featur
seldi
found
sar
patient
similar
serum
proteom
profil
specif
proteom
featur
sensit
specif
rang
respect
combin
biomark
produc
sarsspecif
fingerprint
immunoglobulin
k
light
chain
presenc
correl
sarscov
viral
load
seem
help
diagnos
infect
serum
amyloid
protein
level
detect
seldi
peptid
map
tandem
mass
spectrometr
analysi
correl
extent
pneumonia
serial
chest
radiograph
monoclon
antibodi
use
identifi
viral
infect
immunofluoresc
stain
western
blot
immunohistolog
antibodi
develop
late
first
week
onset
symptom
specif
igg
antibodi
seroconvers
found
patient
day
cell
stimul
produc
antibodi
kill
infect
cell
respect
proinflammatori
cytokin
releas
activ
macrophag
believ
contribut
local
inflamm
contribut
sar
patholog
specimen
suspect
sar
patient
must
handl
use
biosafeti
laboratori
level
practic
facil
specimen
store
secur
place
use
precaut
strict
access
control
inventori
specimen
inventori
audit
frequent
interv
unneed
specimen
steril
discard
accord
protocol
personnel
appropri
train
precaut
retrain
design
interv
drill
conduct
laboratori
procedur
audit
regular
basi
commun
hospit
gener
acidfast
bacilli
room
close
separ
negativepressur
room
biolog
safeti
hood
vent
high
effici
particul
air
hepa
filter
may
adapt
handl
specimen
viral
isol
cultur
must
never
attempt
facil
permit
facil
postmortem
examin
sar
patient
undertaken
special
design
laboratori
facil
physic
separ
rest
health
care
facil
divid
section
clean
area
semicontamin
area
contamin
area
buffer
zone
ventil
system
separ
remaind
build
laminar
flow
clean
area
progress
contamin
area
neg
pressur
clean
semicontamin
contamin
area
pressur
gradient
tap
water
sewag
system
use
person
protect
equip
must
strictli
adher
mortuari
must
adjac
buffer
zone
next
contamin
autopsi
room
downdraft
tabl
ventil
system
hepa
filtrat
must
employ
detail
describ
ref
ref
therein
bacteri
communityacquir
pneumonia
may
result
ard
mistaken
sarscov
infect
includ
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
communityassoci
methicillinresist
staphylococcu
aureu
atyp
pneumonia
eg
legionella
speci
differenti
diagnosi
virus
commonli
caus
ard
fever
includ
season
influenza
b
parainfluenza
viru
avian
influenza
respiratori
syncyti
viru
adenoviru
varicella
hmpv
hantaviru
organ
like
requir
mass
critic
care
potenti
spread
diseas
hcw
result
extens
commun
epidem
high
morbid
mortal
smallpox
viral
hemorrhag
fever
plagu
tularemia
anthrax
aerosol
sarscov
viral
droplet
mm
oppos
droplet
produc
cough
sneez
talk
sarscov
remain
viabl
sever
day
normal
ambient
room
temperatur
humid
suspect
patient
must
immedi
isol
use
contact
droplet
airborn
isol
precaut
negativepressur
singl
room
studi
viru
detect
air
negativepressur
room
patient
mechan
ventil
filter
exhal
circuit
extub
viral
inactiv
method
agent
list
tabl
immun
sarscov
achiev
anim
model
induct
neutral
antibodi
use
liveattenu
vaccinia
viru
ankara
express
glycoprotein
vaccin
recombin
spike
protein
polypeptid
vaccin
gener
escherichia
coli
spike
polypeptid
dna
adenoviralbas
express
either
n
protein
viru
recombin
baculoviru
newcastl
diseas
viru
attenu
vesicular
stomat
viru
express
protein
attenu
salmonella
enterica
serovar
typhi
serovar
typhimurium
protein
lactobacillu
casei
rhabdovirusbas
vaccin
attenu
parainfluenza
viru
express
protein
inactiv
sarscov
vaccin
among
other
comprehens
review
vaccin
develop
referenc
human
monoclon
antibodi
hmab
r
direct
sarscov
protein
act
viral
entri
inhibitor
block
bind
receptor
protect
mice
infect
protect
murin
lung
acut
lung
injuri
sarsspik
proteinmedi
lung
injuri
sarscov
strain
first
outbreak
could
neutral
hmab
sarscov
strain
second
sar
outbreak
resist
product
two
hmab
product
abl
neutral
strain
isol
first
sar
outbreak
urbani
isol
palm
civet
use
noncompet
hmab
may
allow
use
lower
dose
result
synergi
prevent
emerg
resist
mutant
sever
acut
respiratori
syndrom
convers
antibodi
neutral
human
sarscov
glycoprotein
enhanc
entri
mediat
civet
viru
glycoprotein
result
occur
antibodi
interact
conform
epitop
human
bind
domain
pathogenfre
chicken
immun
inactiv
sarscov
produc
egg
antiigi
egg
yolk
antisarscov
antibodi
extract
product
neutral
titer
could
lyophil
reconstitut
without
loss
activ
maintain
good
thermal
stabil
theoret
treatment
includ
treatment
sar
ard
block
pulmonari
reninangiotensin
system
treatment
uncontrol
trial
suggest
ifn
synthet
interferon
steroid
proteas
inhibitor
ribavirin
convalesc
plasma
neutral
antibodi
may
use
treatment
investig
suggest
consid
prophylaxi
ifn
hyperimmun
globulin
unprotect
exposur
hybrid
ifn
ifna
bd
mismatch
doublestrand
ds
rna
ifn
induc
ampligen
poli
poli
also
display
antivir
activ
random
control
trial
avail
evalu
treatment
regimen
earli
posit
outcom
use
ribavirin
steroid
led
widespread
use
combin
studi
case
laboratori
confirm
antibiot
ribavirin
plu
stepdown
steroid
therapi
puls
methylprednisolon
rescu
result
mortal
patient
older
year
complic
suffer
patient
includ
hyperglycemia
pneumomediastinum
psychiatr
symptom
ventil
associ
pneumonia
steroid
therapi
includ
puls
steroid
use
critic
ill
patient
highdos
prolong
steroid
therapi
predispos
patient
multipl
advers
outcom
especi
avascular
necrosi
studi
patient
report
demonstr
ribavirin
antivir
activ
synergi
type
ifn
leukocyt
ifna
subsequ
report
indic
ribavirin
mizoribin
monophosph
dehydrogenas
inhibitor
poor
vitro
antivir
activ
associ
frequent
toxic
concern
exist
advers
effect
ribavirin
effect
includ
dosedepend
anemia
dose
gd
greater
day
hemolysi
bone
marrow
suppress
arrhythmia
elev
lactat
pyruv
level
hypocalcemia
hypomagnesemia
patient
complain
chest
pain
dizzi
less
frequent
patient
develop
hyperuricemia
hyperbilirubinemia
interstiti
pneumonia
leukopenia
thrombocytopenia
ribavirin
therapi
result
anemia
patient
decreas
gdl
hemoglobin
hypoxem
anem
patient
receiv
ribavirin
higher
mortal
indomethacin
signific
vitro
antisarscov
activ
antiinflammatori
agent
chloroquin
amodiaquin
pentoxifyllin
inact
vitro
niclosamid
sever
interferon
demonstr
vitro
vero
cell
activ
sever
nucleosid
analogu
proteas
inhibitor
revers
transcriptas
inhibitor
neuraminidas
inhibitor
amantadin
foscarnet
adequ
inhibit
cytopath
effect
ritonavirlopinavir
kaletra
human
immunodefici
viru
proteas
inhibitor
combin
mg
ritonavir
mg
lopinavir
suggest
earli
treatment
sar
ifn
although
recommend
standard
therapi
possess
vitro
antivir
activ
case
report
suggest
subject
clinic
trial
studi
combin
lopinavirritonavir
ribavirin
result
lower
incid
intub
match
cohort
vs
respect
ard
death
versu
histor
control
p
week
novel
covinhibit
agent
seem
theoret
promis
includ
carbohydratebind
agent
nucleosid
analogu
nucleobas
ranpirnas
onconas
amphibian
oocyteearli
embryo
ribonucleas
drug
target
viral
envelop
protein
safeti
test
equin
antisarscov
f
ab
undertaken
macaqu
patent
applic
cathepsin
l
inhibitor
inhibitor
sarscov
entri
cell
sarscov
proteas
inhibitor
ifn
short
interf
rna
inhibit
express
sarscov
gene
either
made
consider
cellular
receptor
sarscov
spike
protein
likewis
therapeut
target
review
sar
therapi
administ
epidem
found
find
clearcut
treatment
benefit
elus
report
inconclus
benefit
report
possibl
harm
relat
ribavirin
therapi
inconclus
report
report
possibl
harm
steroid
therapi
inconclus
report
lipinavirritonavir
therapi
ifna
therapi
convalesc
plasma
immunoglobulin
therapi
virusencod
enzym
cystein
proteas
papainlik
cystein
proteas
nucleosid
triphosph
hydrolasehelicas
rnadepend
rna
polymeras
consid
therapeut
target
compound
exhibit
vitro
activ
includ
valinomycin
glycopeptid
antibiot
plant
lectin
hesperetin
glycyrrhizin
aurintricarboxyl
acid
niclosamid
nelfinavir
calpain
inhibitor
unto
breach
dear
friend
close
wall
english
dead
peac
noth
becom
man
modest
still
humil
blast
war
blow
ear
imit
action
tiger
stiffen
sinew
summon
blood
william
shakespear
henri
v
identif
possibl
sar
patient
must
made
admiss
hospit
symptom
almost
alway
overlap
common
respiratori
diseas
present
commun
make
epidemiolog
histori
critic
rapid
definit
laboratori
test
patient
hcw
must
avail
recogn
patient
risk
sar
becom
difficult
task
result
bioterrorist
attack
patient
first
present
institut
placement
patient
negativepressur
room
strict
enforc
infect
control
measur
use
person
protect
equip
essenti
use
close
oxygen
deliveri
mask
respiratori
filter
mandatori
patient
requir
supplement
oxygen
regular
screen
hcw
nasopharyng
carriag
may
necessari
addit
laboratori
need
warn
possibl
sarscov
infect
soon
possibl
danger
nosocomi
spread
hcw
laboratoryacquir
infect
signific
even
implement
infect
control
practic
shown
amoy
garden
outbreak
sar
may
repres
environment
hazard
contamin
viral
aerosol
associ
plumb
definit
treatment
modal
ribavirin
steroid
therapi
seem
frequent
choic
clinician
epidem
yet
lack
clear
evid
benefit
horsesho
bat
natur
reservoir
sarscov
civet
amplif
host
wet
market
farm
amplif
center
sarscov
signific
similar
avian
cov
sarscovlik
virus
found
mammal
mask
palm
civet
racoon
dog
chines
liveanim
market
polymeras
gene
mammalian
origin
wherea
end
structur
gene
exclud
glycoprotein
avian
origin
glycoprotein
felin
avian
origin
sarscov
rapidli
evolv
group
cov
still
circul
anim
reservoir
readi
reemerg
caus
new
epidem
challeng
face
health
care
institut
includ
closur
icu
bed
loss
staff
quarantin
ill
emerg
introduct
new
complex
restrict
infect
control
procedur
rapid
staff
educ
system
plan
maintain
moral
booth
stewart
toronto
indic
coordin
leadership
commun
infrastructur
system
place
quickli
expand
modifi
critic
care
servic
essenti
meet
demand
sar
outbreak
